?Np63 promotes IGF1 signalling through IRS1 in squamous cell carcinoma.

ABSTRACT: Accumulating evidence has proved that deregulation of ?Np63 expression plays an oncogenic role in head and neck squamous cell carcinomas (HNSCCs). Besides p63, the type 1-insulin-like growth factor (IGF) signalling pathway has been implicated in HNSCC development and progression. Most insulin/IGF1 signalling converges intracellularly onto the protein adaptor insulin receptor substrate-1 (IRS-1) that transmits signals from the receptor to downstream effectors, including the PI3K/AKT and the MAPK kinase pathways, which, ultimately, promote proliferation, invasion, and cell survival. Here we report that p63 directly controls IRS1 transcription and cellular abundance and fosters the PI3K/AKT and MAPK downstream signalling pathways. Inactivation of ?Np63 expression indeed reduces tumour cell responsiveness to IGF1 stimulation, and inhibits the growth potential of HNSCC cells. In addition, a positive correlation was observed between p63 and IRS1 expression in human HNSCC tissue arrays and in publicly available gene expression data. Our findings indicate that aberrant expression of ?Np63 in HNSSC may act as an oncogenic stimulus by altering the IGF signalling pathway.

SUBMITTER: Frezza V 

PROVIDER: S-EPMC6326668 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature